Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

A new survey shows that most people would rather try dieting to lose weight than take the latest injectable drugs like ...

Rice is part of multiuniversity research team that has secured $34.9 million from ARPA-H to accelerate the development of a ...

GlucoRedi is a supplement product that helps control blood sugar levels. It has a compelling blend of organic antioxidants ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...

Dr. Christopher McGowan, MD, an obesity medicine specialist at True You Weight Loss, says the decision to drink on Ozempic is ...

The best treatment will depend on the individual, but the main options will be dietary measures and increased activity levels. Childhood obesity is reversible through treatment and lifestyle ...

Three Fool.com contributors have identified what they believe are no-brainer growth stocks to buy in October. Here's why they picked Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex ...

Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being "extremely effective" ...

Typically, the first treatment for people with obesity ... Qsymia, pronounced Kyoo-sim-ee-uh, is informally known as obesity medicine experts’ best-kept weight loss secret.

We recently compiled a list of 7 Best Russell 2000 Stocks to Buy According to Analysts. In this article, we will look at ...